Inhibrx Biosciences, Inc. (US: INBX) — Healthcare · Share Price, Chart & Market Data
About: Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, which is in phase 1, a tetravalent therapeutic candidate targeting death-receptor 5 to treat unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head non-small cell lung cancer cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, and urothelial cell carcinoma. Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $129.06 (+7.61%)
INBXInhibrx Biosciences, Inc.
Loading watchlist status…
Trade INBX now
Inhibrx Biosciences, Inc. share price
INBX price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 12:23 pm GMT+0
INBX price performance
53.497%
5D
121.031%
1M
71.988%
YTD
945.02%
1Y
INBX price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 12:23 pm GMT+0
INBX details
INBX Market Signals